CRGN Curagen Corp. (MM)

BRANFORD, Conn., Nov. 5 /PRNewswire-FirstCall/ -- CuraGen Corporation (NASDAQ:CRGN), a clinical-stage biopharmaceutical company focused on oncology, announced today that Dr. Timothy M. Shannon, President and Chief Executive Officer, will present a corporate update at the Rodman & Renshaw Annual Global Investment Conference on Wednesday, November 12, 2008, at 3:15 p.m. Eastern time. The conference is being held at the New York Palace Hotel in New York, NY. Access to a live webcast of the presentation will be available from the Investor Relations section of CuraGen's website at http://www.curagen.com/. A replay of the webcast will be available after the presentation and archived for 90 days thereafter. About CuraGen CuraGen Corporation (NASDAQ:CRGN) is a dedicated clinical-stage biopharmaceutical company developing diverse approaches for the treatment of cancer. CuraGen Corporation is headquartered in Branford, Connecticut. For additional information please visit http://www.curagen.com/. CRGN-G Contacts: Sean Cassidy Vice President and Chief Financial Officer (203) 871-4400 Glenn Schulman, PharmD Director of Medical Communications (888) 436-6642 DATASOURCE: CuraGen Corporation CONTACT: Sean Cassidy, Vice President and Chief Financial Officer, +1-203-871-4400, , or Glenn Schulman, PharmD, Director of Medical Communications, +1-888-436-6642, , both of CuraGen Corporation Web Site: http://www.curagen.com/

Copyright